VA would study cannabis use among veterans enrolled in its health system who have chronic pain or post-traumatic stress disorder (PTSD).
VA would run an 18-month study of cannabis benefits and harms among veterans enrolled in VA health care who have chronic pain or post-traumatic stress disorder.
VA would run cannabis trials for veterans enrolled in its care who have chronic pain or PTSD if it finds it can meet trial requirements. Excessive risks or unmet clinical requirements could halt trials.
Veterans’ research participation would not affect their eligibility for other benefits. VA would also protect participants’ identities and preserve research data for future studies.
VA would conduct an observational study, examining health outcomes linked to cannabis use. The study would cover veterans enrolled in VA health care who have chronic pain or post-traumatic stress disorder. VA would start within 180 days of enactment and run the study for 18 months. It would report to Congress within 90 days of completion.
VA would conduct cannabis trials if its initial study report finds it can meet the requirements for those trials. Trials would cover veterans enrolled in VA health care who have chronic pain or PTSD. The cannabis would have to meet FDA requirements for research use. VA could stop trials if it cannot meet clinical requirements or finds excessive risks to participants. VA would begin trials within 180 days after submitting the initial study report.
VA would preserve research data and keep participation from affecting veterans’ other benefits. These protections would cover veterans enrolled in VA health care who take part in research under the bill. Research data would have to be anonymous, so it could not be traced to an individual patient.
No hearings or votes scheduled.